Science


The latest piece on psychedelic science in the New York Times is dead wrong


First, the entire premise—that Schedule I status is the primary obstacle to research—is flat-out wrong.

We need ecstasy and opioids in place of Prozac and Xanax


Instead of worrying so much about addiction, which tends to correct itself when life becomes tolerable, maybe we should worry more about the sources of emotional suffering.

Dennis McKenna on his ethnopharmacology conference 50 years in the making


It’s been 50 years since the last one. The original idea was to hold followups every 10 years. But the war on drugs came along, and they were never held. It’s time to take another look at the current state of the art.

Psychedelics Can’t be Tested Using Conventional Clinical Trials


Should these drugs become part of medicine cabinets from San Francisco to America’s heartland, it will be high time to develop drug tests that control for the cultural diversity of this country’s doctors and patients.

A Short History of Psychedelic Psychotherapy, Pt. 2


Let’s go forward in time through the government’s ban on psychedelics, and look how it has blossomed into the psychedelic renaissance.

A Short History of Psychedelic Psychotherapy, Pt. 1


Psychotherapy-assisted psychedelic experiences may revolutionize how we treat mental illness. The philosophy and techniques have evolved over the past 50 years.

I received the largest dose of psilocybin ever administered in a published FDA study. Dose #3


Part 3 | Dose #3 was the most intense, powerful, horrendous, terrifying, awful experience of my life. In the end, it was all worth it.

I received the largest dose of psilocybin ever administered in a published FDA study. Dose #2


Part 2 | This time my dose was 45 mg of pure psilocybin. I took it and waited for the show to begin. There was fear and a sincere hope that this experience would not be as hellish.

I received the largest dose of psilocybin ever administered in a published FDA study. Dose #1


A 3-part series on one participant's high dose psilocybin experience in the Pharmacokinetics of Psilocybin in Normal Adult Volunteers study at the University of Wisconsin.

Precautions with Underground Psychedelic Therapy


In underground sessions, you’re taking a huge risk choosing to work with someone who may not have adequately prepared or may have dubious subconscious motivations.

Do psychedelics trigger neurogenesis? Here’s what we know.


What is neurogenesis? Do psychedelics really cause it? If they do, what doors might that open up?

Non-PTSD Uses for MDMA


While much progress has been made, a narrow focus of MDMA just for PTSD obscures the larger applications of MDMA, particularly for those whom traditional psychotherapy has been largely ineffective.

How Does LSD Induce Short-Term Psychosis but Long-Term Optimism?


There’s only one way to find out – more scientific experiments.

Finding The Sweet Spot: At 62 I Had My First Dose Of Psilocybin At Johns Hopkins


A research program was seeking volunteers with a spiritual background to ingest a hallucinogen.

Winter Blues Got You Down? Try These Integrative Antidepressant Approaches


Here's some integrative antidepressant approaches that have low or no side effects and won't cost you an arm and a leg.

My First Psychedelic Experience at Johns Hopkins Changed My Life


It’s been more than six years since I participated in the Johns Hopkins Spirituality study, but it continues as the most life-changing event of my life.

Psychedelic Frontiers of Western Medicine


Johns Hopkins and Yale Schools of Medicine reviewed dozens of studies and recent trials on psychedelic compounds.

A Divine Encounter In The Johns Hopkins Psilocybin Study


"On Tuesday, you will be the only person in the U.S. who will be taking psilocybin legally.”

We Talked with World Ayahuasca Conference Organizer Ben De Loenen


"Too many people just see ayahuasca as a sales product and that’s a problem, where it becomes commodified."

Canada Approves Legal Heroin For Severely Addicted Patients


Canada has amended its policies on heroin to allow doctors to prescribe the drug to patients suffering severe addiction.

Science


The latest piece on psychedelic science in the New York Times is dead wrong


First, the entire premise—that Schedule I status is the primary obstacle to research—is flat-out wrong.

We need ecstasy and opioids in place of Prozac and Xanax


Instead of worrying so much about addiction, which tends to correct itself when life becomes tolerable, maybe we should worry more about the sources of emotional suffering.

Dennis McKenna on his ethnopharmacology conference 50 years in the making


It’s been 50 years since the last one. The original idea was to hold followups every 10 years. But the war on drugs came along, and they were never held. It’s time to take another look at the current state of the art.

Psychedelics Can’t be Tested Using Conventional Clinical Trials


Should these drugs become part of medicine cabinets from San Francisco to America’s heartland, it will be high time to develop drug tests that control for the cultural diversity of this country’s doctors and patients.

A Short History of Psychedelic Psychotherapy, Pt. 2


Let’s go forward in time through the government’s ban on psychedelics, and look how it has blossomed into the psychedelic renaissance.

A Short History of Psychedelic Psychotherapy, Pt. 1


Psychotherapy-assisted psychedelic experiences may revolutionize how we treat mental illness. The philosophy and techniques have evolved over the past 50 years.

I received the largest dose of psilocybin ever administered in a published FDA study. Dose #3


Part 3 | Dose #3 was the most intense, powerful, horrendous, terrifying, awful experience of my life. In the end, it was all worth it.

I received the largest dose of psilocybin ever administered in a published FDA study. Dose #2


Part 2 | This time my dose was 45 mg of pure psilocybin. I took it and waited for the show to begin. There was fear and a sincere hope that this experience would not be as hellish.

I received the largest dose of psilocybin ever administered in a published FDA study. Dose #1


A 3-part series on one participant's high dose psilocybin experience in the Pharmacokinetics of Psilocybin in Normal Adult Volunteers study at the University of Wisconsin.

Precautions with Underground Psychedelic Therapy


In underground sessions, you’re taking a huge risk choosing to work with someone who may not have adequately prepared or may have dubious subconscious motivations.

Do psychedelics trigger neurogenesis? Here’s what we know.


What is neurogenesis? Do psychedelics really cause it? If they do, what doors might that open up?

Non-PTSD Uses for MDMA


While much progress has been made, a narrow focus of MDMA just for PTSD obscures the larger applications of MDMA, particularly for those whom traditional psychotherapy has been largely ineffective.

How Does LSD Induce Short-Term Psychosis but Long-Term Optimism?


There’s only one way to find out – more scientific experiments.

Finding The Sweet Spot: At 62 I Had My First Dose Of Psilocybin At Johns Hopkins


A research program was seeking volunteers with a spiritual background to ingest a hallucinogen.

Winter Blues Got You Down? Try These Integrative Antidepressant Approaches


Here's some integrative antidepressant approaches that have low or no side effects and won't cost you an arm and a leg.

My First Psychedelic Experience at Johns Hopkins Changed My Life


It’s been more than six years since I participated in the Johns Hopkins Spirituality study, but it continues as the most life-changing event of my life.

Psychedelic Frontiers of Western Medicine


Johns Hopkins and Yale Schools of Medicine reviewed dozens of studies and recent trials on psychedelic compounds.

A Divine Encounter In The Johns Hopkins Psilocybin Study


"On Tuesday, you will be the only person in the U.S. who will be taking psilocybin legally.”

We Talked with World Ayahuasca Conference Organizer Ben De Loenen


"Too many people just see ayahuasca as a sales product and that’s a problem, where it becomes commodified."

Canada Approves Legal Heroin For Severely Addicted Patients


Canada has amended its policies on heroin to allow doctors to prescribe the drug to patients suffering severe addiction.

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1